Detalhe da pesquisa
1.
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?
Breast Cancer Res Treat
; 205(1): 5-16, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265568
2.
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer.
Breast Cancer Res Treat
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627318
3.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Lancet Oncol
; 15(9): 943-53, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25035291
4.
FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer.
Cell Rep
; 39(1): 110584, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385742
5.
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Clin Cancer Res
; 28(5): 960-971, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965952
6.
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01).
Breast Care (Basel)
; 16(6): 598-606, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087363
7.
Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.
Eur J Cancer
; 74: 47-54, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28335887
8.
Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.
Oncotarget
; 8(69): 113531-113542, 2017 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371927
9.
Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer.
J Clin Oncol
; 23(15): 3331-42, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15908647
10.
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.
Cancer Res
; 76(3): 525-34, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26762204
11.
USP9X downregulation renders breast cancer cells resistant to tamoxifen.
Cancer Res
; 74(14): 3810-20, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25028367
12.
Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide.
BMJ Case Rep
; 20122012 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23008380